REZOLUTE INC. - COMMON STOCK (NV)
4,8100
24-января-25 16:45:00
15 мин. задержка
Акции
-0,1800
-3,61%
Сегодняшний диапазон
4,8000 - 5,0423
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
24 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
23 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism
14 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)
13 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day
17 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute Reports First Quarter Fiscal 2024 Results
13 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
17 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute Announces Further Evidence of RZ358’s Efficacy in Tumor-Mediated Hyperinsulinism
11 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress
14 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Rezolute to Participate in Upcoming Investor Conferences in September
06 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
27 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress
11 май 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema
23 мар 2023 16:50:08 Источник Nasdaq GlobeNewswire
-
Rezolute to Highlight RZ402 Phase 2 Clinical Program with Leading Clinical Expert
08 мар 2023 07:00:02 Источник Nasdaq GlobeNewswire
-
Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress
10 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular Edema
15 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress
09 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
Rezolute to Present at the Jefferies London Healthcare Conference
01 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting
20 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress
15 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire